Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for WN.TO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for WN.TO and 80,000+ other tickers.
See exactly how WN.TO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for WN.TO and 80,000+ other tickers.
George Weston Limited is a diversified Canadian and international enterprise, primarily engaged in food and drug retailing, alongside offering financial services. Its operations are structured into two main segments: Loblaw Companies Limited (Loblaw) and Choice Properties Real Estate Investment Trust (Choice Properties). The Loblaw division encompasses a broad array of retail offerings, including groceries, pharmaceuticals, health and beauty products, apparel, general merchandise, and financial solutions. It notably operates drugstores under the Shoppers Drug Mart brand. Furthermore, Loblaw…
No recent news available.